Chembio Diagnostics (CEMI) Reports Q2 GAAP Loss of $0.86/Share

August 11, 2016 8:34 AM EDT
Get Alerts CEMI Hot Sheet
Trade CEMI Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Chembio Diagnostics (NASDAQ: CEMI) reported Q2 EPS of ($0.86), versus ($0.07) reported last year. Revenue for the quarter came in at $3.27 million, versus $6.72 million reported last year.

The net loss in the 2016 period includes a tax provision for the recording of a valuation allowance on the Company's deferred tax asset of $5,963,000.

For earnings history and earnings-related data on Chembio Diagnostics (CEMI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment